Dry Eye Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
SKU : PH1352
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Dry Eye Syndrome Market ?
Global Dry Eye Syndrome Market reached USD 5.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 10.4 billion by 2031.
Who are the key players in Dry Eye Syndrome Market?
Key players are Novartis AG, AbbVie, Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co., Ltd., AFT Pharmaceuticals, Johnson & Johnson Services, Inc., Otsuka Pharmaceutical Co., Ltd., OASIS Medical, Oyster Point Pharma, Inc. and Bausch & Lomb. 
Related Reports
pharmaceuticals

Formulation Development Outsourcing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 February 01
Starting from

$4350

pharmaceuticals

Dental Cement Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 July 22
Starting from

$4350

pharmaceuticals

Xerophthalmia Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 January 06
Starting from

$4350

pharmaceuticals

Tourette Syndrome Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

POEMS Syndrome Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 January 06
Starting from

$4350

pharmaceuticals

Short Bowel Syndrome Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 October 16
Starting from

$4350